EPOGEN is a Intravenous; Subcutaneous Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Erythropoietin.
Product ID | 55513-478_0b8ee1a8-d7d1-46c9-b688-6fbd8dcaccca |
NDC | 55513-478 |
Product Type | Human Prescription Drug |
Proprietary Name | EPOGEN |
Generic Name | Epoetin Alfa |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 1997-03-03 |
Marketing Category | BLA / BLA |
Application Number | BLA103234 |
Labeler Name | Amgen Inc |
Substance Name | ERYTHROPOIETIN |
Active Ingredient Strength | 20000 [iU]/mL |
Pharm Classes | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [CS],Increased Erythroid Cell Production [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1997-03-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103234 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1997-03-03 |
Marketing Category | BLA |
Application Number | BLA103234 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1997-03-03 |
Ingredient | Strength |
---|---|
ERYTHROPOIETIN | 20000 [iU]/mL |
SPL SET ID: | 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
55513-126 | EPOGEN | epoetin alfa |
55513-144 | EPOGEN | epoetin alfa |
55513-148 | EPOGEN | epoetin alfa |
55513-267 | EPOGEN | epoetin alfa |
55513-283 | EPOGEN | epoetin alfa |
55513-478 | EPOGEN | epoetin alfa |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EPOGEN 73699422 1543197 Live/Registered |
AMGEN INC. 1987-12-07 |